Oncology PracticeAdverse effects of PD-1/PD-L1 inhibitors varied by tumor type in systematic reviewAugust 28, 2017Immuno-oncologyImmunotherapyMelanomaRenal Cell CarcinomaLung Cancer
Oncology PracticeCalifornia study indicates increased melanoma incidence is realAugust 8, 2017Melanoma
Hospital Physician: Hematology/OncologyTargeted Therapy and Immunotherapy in the Treatment of Metastatic Cutaneous MelanomaJuly 1, 2017ImmunotherapyMelanoma
Oncology PracticeVIDEO: Immune therapy effective, durable in treatment-naive melanoma brain metastasesJune 12, 2017MelanomaImmuno-oncologyImmunotherapyCNS/Brain Cancer
Oncology PracticeImmediate-completion lymph node dissection in metastatic melanomaJune 11, 2017Melanoma
Oncology PracticeSkin cancer procedures up by 35% since 2012June 8, 2017Nonmelanoma Skin CancerMelanoma
Oncology PracticeTRK inhibitor shows ‘striking’ activity, durability across diverse adult and pediatric cancersJune 5, 2017Sarcoma & GISTMelanomaGastroenterologyRare DiseasesGastrointestinal Cancer
Oncology PracticeImmune-agonist combo has activity against several tumor typesJune 5, 2017Immuno-oncologyImmunotherapyBreast CancerMelanomaRenal Cell CarcinomaGynecologic CancerGenitourinary Cancer
Oncology PracticeHow to best evaluate children’s melanocytic lesions for melanomaJune 1, 2017PediatricsPreventive CareMelanoma
Oncology PracticeMole count predicted melanoma death, especially among menMay 24, 2017MelanomaPreventive Care
Oncology PracticeSLE linked to subsequent risk of malignant melanomaMay 11, 2017MelanomaPreventive CareImmuno-oncology
Oncology PracticeStudy finds psoriasis link to melanoma and hematologic cancersApril 20, 2017MelanomaLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Oncology PracticeGet ready for cancer immunotherapy-induced rheumatic diseasesApril 3, 2017ImmunotherapyMelanomaMultiple MyelomaImmuno-oncology
Oncology PracticeConnective tissue diseases reported in patients receiving immune checkpoint inhibitorsMarch 3, 2017Patient & Survivor CareImmunotherapyAggressive LymphomasMelanomaImmuno-oncology
